About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Is Treatment-free Remission of Chronic Myeloid Leukemia Achievable?

by Hannah Joy on February 20, 2018 at 1:31 PM
Font : A-A+

Is Treatment-free Remission of Chronic Myeloid Leukemia Achievable?

Treatment-free remission (TFR) can be achieved for patients with chronic myeloid leukemia (CML) who have deep molecular response (DMR) following discontinuation of second-line nilotinib therapy.

Treatment-free remission, or stopping TKI therapy without loss of response, is an emerging treatment goal for patients with CML in chronic phase.

Advertisement


The results from a Phase 2, open-label study were published in Annals of Internal Medicine.

Tyrosine kinase inhibitors (TKIs), such as imatinib, nilotinib, dasatinib, and bosutinib, have dramatically improved outcomes for patients with CML.
Advertisement

Potential benefits of treatment-free remission include relief of treatment side effects, reduced risk for long-term TKI toxicity, and the ability to plan a family.

In the STIM1 (Stop Imatinib 1) trial, 38 percent of patients with sustained DMR while receiving long-term imatinib treatment had molecular recurrence-free survival at 5 years.

These results confirm the feasibility of treatment-free remission after sustained DMR in patients receiving TKI.

Researchers from South Australian Health and Medical Research Institute studied 163 patients who had achieved sustained DMR after switching from imatinib to nilotinib to determine if they could maintain remission without TKI.

They found that most of those patients maintained treatment-free remission for 48 weeks or longer.

In addition, for those who do not achieve sustained DMR with imatinib, switching to nilotinib may enable more patients to become eligible for treatment-free remission.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
Smallpox
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Leukemia Chronic Myeloid Leukemia Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Multiple Myeloma Bone Marrow Transplantation Hairy Cell Leukemia 

Recommended Reading
Chronic Myeloid Leukemia
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by .....
World Chronic Myeloid Leukemia Day: Today, Together We are Treated, Tomorrow We Need Cure
World Chronic Myeloid Leukemia Day is celebrated on 22nd September because 9/22 represents the ......
Chronic Myeloid Leukemia Yet to be Defeated
Despite accomplishing significant progress in treating chronic myeloid leukemia, the disease cannot ...
Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lympho...
Acute Myeloid Leukemia
Acute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving leukem...
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are in...
Hairy Cell Leukemia
Hairy cell leukemia (HCL) is a type of leukemia where there are increased numbers of abnormal B-lymp...
Leukemia
Encyclopedia section of medindia gives general information about Leukemia...
Multiple Myeloma
Multiple Myeloma caught public attention when model turned actress Lisa Ray, who worked in Deepa Meh...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use